Annual Meeting GI 2016 : Pembrolizumab more value in squamous cell carcinomas or adenocarcinomas

admin

8 years ago

Dr. Toshihiko Doi, MD of National Cancer Center Hospital East, Japan discusses Pembrolizumab more value in squamous cell carcinomas or adenocarcinomas at ASCO GI 2016